Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2021 11:17 ET | Source: Coya Therapeutics

Coya Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference

HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells...
April 14, 2021 07:00 ET | Source: Coya Therapeutics

Coya Therapeutics™ Announces the Appointment of Hideki Garren, M.D., Ph.D., and Dov Goldstein, M.D., to Its Board of Directors

HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells...
February 23, 2021 07:00 ET | Source: Coya Therapeutics

Coya Therapeutics™ Announces Formation of Scientific Advisory Board

HOUSTON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Coya Therapeutics, Inc., (Coya™), a clinical-stage biotechnology company developing first-in-class approaches that utilize autologous regulatory T cells...
February 03, 2021 07:00 ET | Source: Coya Therapeutics

Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell Therapeutics Optimized for Neurodegeneration and Autoimmune Diseases

-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and...